CLRB Cellectar BioSciences
- 2.0400
- +0.1300+6.81%
- 2.0000
- -0.0400-1.96%
Cellectar BioSciences News
Cellectar BioSciences | 8-K: Current report
Cellectar BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rosalind Advisors, Inc.(9.9%),Steven Salamon(9.9%), etc.
Cellectar BioSciences | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Cellectar BioSciences | 8-K: Current report
Cellectar BioSciences | 8-K: Current report
Cellectar BioSciences | EFFECT: Others
Cellectar BioSciences | 8-K: Current report
Cellectar BioSciences | CORRESP: CORRESP
Cellectar BioSciences | 8-K: Current report
Cellectar BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rosalind Advisors, Inc.(9.9%),Steven Salamon(9.9%), etc.
Cellectar BioSciences | 8-K: Current report
Cellectar BioSciences | 8-K: Current report
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer CARUSO JAMES V
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Longcor Jarrod
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Kolean Chad J
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Shustov Andrei
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Officer Lea Darrell Shane
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Chanan-Khan Asher
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Director DRISCOLL FREDERICK W
Cellectar BioSciences | 4: Statement of changes in beneficial ownership of securities-Director Loren Stefan
Analysis
Price Target
No Data
No Data